Pfizer Inc. has entered into a five-year corporate integrity agreement as part of a settlement with the Department of Justice to resolve claims it used a foundation as a conduit to fund the copays of Medicare patients taking three of its drugs in violation of the Anti-Kickback Statute and the False Claims Act.
The
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?